Pfizer weighs sale of women’s health portfolio: Bloomberg

Pfizer Inc is considering selling its women’s health portfolio as it looks to focus on developing 
treatments with higher growth potential, Bloomberg said. A sale of the division could fetch about $2 billion, the story said.